| Specific enhancer selection by IRF3, IRF5 and IRF9 is determined by ISRE half-sites, 5′ and 3′ flanking bases, collaborating transcription factors and the chromatin … M Csumita, A Csermely, A Horvath, G Nagy, F Monori, L Göczi, HA Orbea, ... Nucleic acids research 48 (2), 589-604, 2020 | 30 | 2020 |
| Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis S Póliska, T Besenyei, E Végh, A Hamar, A Pusztai, A Váncsa, N Bodnár, ... Arthritis research & therapy 21 (1), 1-11, 2019 | 8 | 2019 |
| AB0024 Genetic Signatures May Be Associated with Vascular Pathology in Rheumatoid Arthritis S Poliska, E Végh, A Váncsa, N Bodnár, S Szamosi, M Csumita, ... Annals of the Rheumatic Diseases 74 (Suppl 2), 898-899, 2015 | 2 | 2015 |
| A Multi-Omics Approach Reveals Features That Permit Robust and Widespread Regulation of IFN-Inducible Antiviral Effectors. L Göczi, M Csumita, A Horváth, G Nagy, S Póliska, M Pigni, C Thelemann, ... Journal of Immunology (Baltimore, Md.: 1950), ji2200363-ji2200363, 2022 | | 2022 |
| AB0009 Genomic signatures may be associated with vascular pathology associated with rheumatoid arthritis S Poliska, E Végh, A Váncsa, S Szamosi, M Csumita, G Zahuczky, ... Annals of the Rheumatic Diseases 76 (Suppl 2), 1049-1049, 2017 | | 2017 |
| 07.02 Genetic signatures in rheumatoid arthritis: changes upon anti-tnf therapy and association with response to biological treatment A Hamar, S Poliska, E Végh, A Pusztai, A Váncsa, S Szamosi, M Csumita, ... Annals of the Rheumatic Diseases 76 (Suppl 1), A67-A67, 2017 | | 2017 |
| AB0012 Genetic Signatures in Rheumatoid Arthritis: Changes upon Anti-TNF Therapy and Association with Response To Biological Treatment S Poliska, E Végh, A Váncsa, S Szamosi, M Csumita, G Zahuczky, ... Annals of the Rheumatic Diseases 75 (Suppl 2), 901-901, 2016 | | 2016 |
